FDA Approves LEUCOVORIN CALCIUM — Epic Pharma LLC

Epic Pharma LLC announced the launch of Leucovorin Calcium as an oral supplement for an ANDA filed in 1997, strengthening its portfolio of chemotherapy support formulations and increasing accessibility to this essential supportive care therapy. The entry of this generic into the market is expected to broaden competition, offering cost-effective alternatives to branded chemo-prevention drugs and potentially impacting pricing structures within the supportive oncology sector.